Sensor monitoring system for in-dwelling catheter based treatments
A patient monitoring system may be used with catheters to monitor the infusion and drainage of any solution into the human body. The system may be used, for example, with in-dwelling catheters for peritoneal dialysis in end stage renal disease (ESRD) patients, urinary tract catheters, insulin pumps in diabetic patients, feeding tubes and central venous line catheters. The patient monitoring system includes one or more fluid pathways for infusing into and/or draining solutions out of the catheter, and one or more sensors to monitor the fluid. The patient monitoring system transmits the patient monitoring data to a database, allowing data storage, processing, and access through graphical user interfaces to patients and providers via device applications or browser-based web access portals.
1. A method of detecting infection of a patient, comprising:
receiving patient fluid through a fluid conduit;
measuring an optical characteristic of the patient fluid at two or more wavelength ranges;
estimating a leukocyte concentration based at least in part on the optical characteristic measurement at the two or more wavelength ranges; and
detecting an infection state of the patient based at least in part on the estimated leukocyte concentration.
2. The method of claim 1 , wherein the optical characteristic comprises one or more of optical scatter and absorption.
3. The method of claim 1 , wherein measuring the optical characteristic at a first wavelength range corresponds to a total particle concentration of the patient fluid and measuring the optical characteristic at a second wavelength range corresponds to a leukocyte concentration of the patient fluid, wherein the first wavelength range is different from the second wavelength range.
4. The method of claim 1 , wherein the first wavelength range is between about 700 nm and about 1 mm and the second wavelength range is between about 260 nm and about 550 nm.
5. The method of claim 1 , wherein measuring the optical characteristic at a first wavelength range corresponds to a total particle concentration of the patient fluid and measuring the optical characteristic at a second wavelength range corresponds to a non-leukocyte particle concentration of the patient fluid, wherein the first wavelength range is different from the second wavelength range.
6. The method of claim 1 , further comprising:
receiving dialysate fluid through the fluid conduit; and
measuring the optical characteristic of the dialysate fluid, wherein the dialysate fluid is to be infused in the patient and the patient fluid is drained from the patient, and the estimated leukocyte concentration is based at least in part on the optical characteristic measurement of the dialysate fluid.
7. The method of claim 6 , further comprising:
estimating an optical characteristic differential between the patient fluid and the dialysate fluid; and
updating the infection state of the patient based at least in part on the optical characteristic differential.
8. The method of claim 1 , further comprising:
measuring one or more of a flow rate and total flow volume of the patient fluid using a flow sensor coupled to the fluid conduit; and
normalizing the optical characteristic measurement based on one or more of the flow rate and total flow volume measurement.
9. The method of claim 8 , further comprising:
detecting one or more of an obstruction and flow direction based at least in part on the flow rate measurement.
10. The method of claim 8 , further comprising:
estimating one or more of an infusion volume, drainage volume, infusion time, drainage time, and dwell time based at least in part on the flow rate measurement; and
estimating one or more of a dialysis efficiency and dialysis adequacy based at least in part on the estimated infusion volume, drainage volume, and dwell time.
11. A method of detecting infection of a patient, comprising:
receiving patient fluid through a fluid conduit;
measuring an optical characteristic of the patient fluid at two or more wavelength ranges;
measuring homogeneity of the patient fluid; and
estimating a leukocyte concentration based at least in part on the optical characteristic measurement at the two or more wavelength ranges and the measured homogeneity, wherein
a set of the optical characteristic measurements are excluded from the leukocyte concentration estimation based at least in part on the measured homogeneity.
12. A patient monitoring device, comprising:
an optical sensor arrangement comprising at least one emitter and at least one detector, the emitter configured to transmit light at one or more wavelength ranges through a patient fluid flowing through a fluid conduit, and the at least one detector configured to receive the light transmitted through the patient fluid and generate signal data based on the received light; and
a controller configured to estimate total particle concentration and leukocyte concentration using the signal data.
13. The patient monitoring device of claim 12 , further comprising:
a housing enclosing the optical sensor arrangement, wherein the fluid conduit is configured to releasably engage to the housing.
14. The patient monitoring device of claim 13 , wherein the housing is configured to transition between an open configuration with an exposed interior cavity and a closed configuration with an enclosed interior cavity.
15. The patient monitoring device of claim 12 , wherein the fluid conduit comprises at least one transparent portion that is substantially transparent to at least one of ultraviolet light, visible light, and infrared radiation.
16. The patient monitoring device of claim 12 , wherein the fluid path comprises an inlet configured to couple to at least one of an in-dwelling catheter and a drain line for peritoneal dialysis, and an outlet configured to open towards a drainage vessel.